Work Here?
GeneFab
Work Here?
Cell and gene therapy CDMO for clinical to commercial supply
GeneFab
Work Here?
Cell and gene therapy CDMO for clinical to commercial supply
Overview
GeneFab is a contract development and manufacturing organization for cell and gene therapies, running cGMP facilities in Alameda, California that support programs from genetic design through commercial supply. The company manufactures ex vivo cell therapies such as CAR-T, TCR-T, CAR-NK, Treg, and iPSC products, plus in vivo lentiviral vector gene therapies at suspension scales up to 200 liters, backed by synthetic biology, process development, analytics, and cell banking. What sets GeneFab apart is its co-development approach, pairing partners with staff who worked on the innovator side and integrating every function under one roof with real-time transparency. The goal is to remove the obstacles between promising science and the patients who need it.
About GeneFab
Industries
Biotechnology
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- July 15, 2026 funding raised Series A to $50 million, backing scale-up.
- RegCell selected GeneFab on May 7, 2025 to move Treg manufacturing from Japan.
- March 2026 ASGCT exposure and two 2026 product launches strengthened partner visibility.
What critics are saying
- Tracxn counted only 57 employees on June 30, 2026, limiting manufacturing bandwidth.
- RegCell remains a key program; any trial delay hits utilization and revenue.
- GeneFab's 2023 founding means no long operating history against Lonza, Fujifilm, and Catalent.
What makes GeneFab unique
- GeneFab combines synthetic biology design, viral vectors, and GMP manufacturing in Alameda.
- Its 42,000-square-foot Alameda site has two segregated cleanroom wings and seven clean rooms.
- On May 4, 2026, GeneFab launched pre-validated promoters and drug-induced switches.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Paternity Leave
Maternity Leave
Professional Development Budget
Conference Attendance Budget
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend
Stock Options
Company Equity
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Parental Leave
Relocation Assistance
Meal Benefits
Employee Referral Bonus
Tuition Reimbursement
Legal Services
Childcare Support
Elder Care Support
Gym Membership
Commuter Benefits
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Training Programs
Tuition Reimbursement
Company News
GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases, to support the tech transfer and clinical manufacturing of RegCell's Treg platform as it transitions from Japan to GeneFab's manufacturing facility in Alameda.
GeneFab is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today
About GeneFab
Industries
Biotechnology
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
GeneFab is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today